A McDonald’s Valuation Downsize, and New Medical Plan Additions
The value of McDonald's China operation has plunged by more than half in the last year. And 91 companies got their drugs added to China's national health plan By Doug…
FAST NEWS: Four Sihuan affiliate products included in China’s national health plan
The latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) announced Tuesday that four non-PVC solid-liquid double chamber bag products developed by its Beijing Ruiye affiliate have been included in the 2023 edition of…
FAST NEWS: Hutchmed swings to profit on strong revenue growth
The latest: Hutchmed (China) Ltd. (HCM.US; 0013.HK) announced Monday a net profit of $169 million in the first half of 2023, reversing a loss of $163 million in the same period…
FAST NEWS: Hutchmed, Zai Lab, Ascentage Drugs Land on China Reimbursement List
The latest: Products from Hutchmed (China) Ltd. (HCM.US; 0013.HK), Zai Lab Ltd. (ZLAB.US; 9688.HK) and Ascentage Pharma Group (6855.HK) were among 111 new drugs selected for new inclusion in the…
FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit
The latest: InnoCare Pharma Ltd. (9969.HK) issued a profit warning Friday, estimating a net loss of no more than 495 million yuan ($73 million) for the first half of this year,…
FAST NEWS: InnoCare Pharma Granted Production Approval for Guangzhou Facility
The latest: InnoCare Pharma Ltd. (9969.HK) announced Monday its Guangzhou manufacturing facility has been approved by the China National Medical Products Administration (NMPA) to start the production of commercial supply of its…
FAST NEWS: Kintor Pharma Soars on Good Results for Covid Drug
The latest: Kintor Pharmaceutical Ltd. (9939.HK) on Wednesday announced positive results from a Phase 3 clinical trial for its drug Proxalutamide for the treatment of mild-to-moderate ambulatory Covid-19 patients, saying…
Recent Articles
RELATED ARTICLES
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK - CHINA BULLETIN: U.S. Ratchets Up Strategic Tariffs
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
- CHINA BULLETIN: Services, Trade Send Positive Signals
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Hong Kong’s Café de Coral takes go-slow approach to Mainland dining market
0341.HK
